Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03933709
Other study ID # 2014/03001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 12, 2015
Est. completion date April 7, 2017

Study information

Verified date April 2019
Source Anahuac University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: Most patients with cerebral palsy (CP) are dependent on parents due to the spasticity and limitations in their gross motor function. Additionally, many of them do not respond to physical therapy due to deterioration in their nutritional status, which is secondary to gastrointestinal disorders, parasitosis, dysbiosis and the catabolic state of the disease itself. Evidence suggests that greater independence and better clinical response can be achieved by correcting the nutritional status. However, basic treatments only contemplate the calculation of energy requirements and do not consider important nutrients in particular, supplementation with glutamine, arginine, zinc, selenium, colecalciferol, nicotinic acid, spirulina, omega 3, ascorbic acid, vegetal protein or even probiotics.

Objective: To determine the effect of using a nutritional support system (NSS) diet, supplements and probiotic on the gross motor function in children with CP with spastic diparesic and Gross Motor Function Classification System III (GMFCS III).

Material and methods: In an exploratory study with controlled clinical trial design, 30 patients were randomly assigned to receive: 1) dietary surveillance and conventional therapy (FG), 2) deworming and WHO diet (CG), or 3) deworming and the NSS (IG). The patients were recruited from the Children´s Telethon Rehabilitation Center (CRIT) in Tlalnepantla Estado de México. Males and females aged 4-12 years were included with CP and spastic diparesic GMFCS III, who had a full-time caregiver and whose parents agreed to participate. They were studied for thirteen weeks. Gross motor function was evaluated at baseline and at 7 and 13 weeks after therapy using the GMFM scale.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date April 7, 2017
Est. primary completion date December 18, 2015
Accepts healthy volunteers No
Gender All
Age group 4 Years to 12 Years
Eligibility Inclusion Criteria:

- Patients with CP with spastic diparesia and GMFCS III

- Re-entry

- Presence and support of a full-time caregiver

- To tolerate oral feeding

- Parents or guardians agree in writing to participate in the project

- Patients treated at the CRIT of Tlalnepantla Edo. Mex

- That the children, in the case of being able to write, accept in writing to participate in the project

Exclusion Criteria:

- Presence of any other catabolic disease, which further increases the risk of malnutrition (renal, cardiovascular, pulmonary, hepatic, immunological)

- Have had infectious problems or have received antibiotic treatment 15 days prior to the start of the study.

- Have received botulinum toxin therapy in the last 4 months

- Muscle relaxants in the last 6 months

- Severe gastroesophageal reflux

- Patients with any type of surgery performed with a period shorter than 9 months

- That can walk by themselves

Study Design


Intervention

Dietary Supplement:
Nutritional Support System (NSS)
Envelope 1 4.9g of Spirulina, 100mg ascorbic acid, 5mg folic acid and 10mg of glutamine. Was to be added to shake 1 during the first 10 days. Envelope 2 1g PUFAs n-3 and was to be added to shake 2 which was given throughout the intervention. Envelope 3 4.9g of Spirulina Maximum, 100mg ascorbic acid, 5mg folic acid, 5.2g vegetable protein, 125mg nicotinic acid, 50mg zinc, 100 mcg selenium and 800 UI cholecalciferol. Was to be added to shake 1 from day 11 until the end of week 6, after which it was suspended for 10 days and substituted for envelope 5 and then to be retaken until the end of the intervention. Envelope 4. 1g arginine and was to be added to shake 3 from day 8 until the end of the intervention. Envelope 5 contained the same ingredients as envelope 3 with an additional 10mg glutamine and was to be added to shake 1 from the start of week 7 for 10 days, after which envelope 3 was restarted. Probiotic at a dosage of 200 mg every 12 hours for 3 days at the beginning and week 6
Other:
deworming
nitazoxanide at a dosage of 7.5 mg / kg every 12 hours for 3 days.
recommended diet
WHO Diet

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Anahuac University

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Gross Motor function Measure at 7 and 13 weeks This scale assesses five general parameters:
Lying (decubitus) and rolling over (GMFAV),
Sitting (GMFB),
Crawling and kneeling (GMFC),
Standing (GMFD),
Walking (GMFE) and one final total item (GMFF).
The scoring system consists of 88 items and each one is valued based on the following criteria:
0= No,
start,
Partially Complete,
Complete, NE= Not evaluated
The GMFM scale was performed at baseline time and weeks 7 and 13 after intervention.
See also
  Status Clinical Trial Phase
Completed NCT03700736 - The Healthy Moms Study: Comparison of a Post-Partum Weight Loss Intervention Delivered Via Facebook or In-Person Groups N/A
Terminated NCT03517111 - The Impact of a Parenting Intervention on Latino Youth Health Behaviors N/A
Completed NCT03675360 - Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial N/A
Completed NCT03792685 - Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention N/A
Recruiting NCT03682640 - Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes Phase 2
Terminated NCT02047136 - Dietary Treatment for Chronic Urticaria N/A
Active, not recruiting NCT05544461 - Piloting a Web-based Personalised Nutrition App (eNutri) With UK University Students N/A
Completed NCT03290118 - The Efficacy of Front-of-package Labelling Schemes: an Experimental Study N/A
Suspended NCT04124016 - Metabotypes in the Urinary Excretion of Flavan-3-ol Metabolites: "Metanols" N/A
Completed NCT03457688 - Effect of Prebiotic Fructans to Reduce Number of Febrile Infections in Children N/A
Completed NCT03241355 - Prebiotic Fructans on the Incidence of Acute Infectious Diseases in Children N/A
Recruiting NCT04616482 - Therapeutic Nutrition With Technology in Primary Care
Recruiting NCT04401605 - Fermented Food-Supplemented Diet in Ulcerative Colitis N/A
Completed NCT03697317 - Televideo Exercise and Nutrition Program for Kidney Transplant Recipients N/A
Completed NCT03748056 - Targeted Food Incentives to Improve Diet Quality and Health Among Adults N/A
Not yet recruiting NCT03657316 - Impact of School Based Education Program N/A
Completed NCT03934476 - The Effects of Lowering Dietary Carbohydrates on Health, Exercise Performance and Wellbeing-related Outcomes N/A
Completed NCT03255603 - Gastrointestinal Assessment of Three Novel RS4 N/A
Completed NCT03129581 - Metabolic Impact of Time Restricted Feeding N/A
Completed NCT03716479 - Gum Acacia and Blood Glucose N/A